MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Business Update
Mind Medicine (MindMed) Inc. plans to host a conference call on November 2, 2023, to provide a corporate update and review its Q3 2023 results.
Positive
Investors can gain insights into MindMed's performance and future prospects during the conference call.
Negative
No negative takes available.
10/26/2023 - 07:30 AM
NEW YORK --(BUSINESS WIRE)--
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it plans to host a conference call on Thursday, November 2, 2023, at 4:30 p.m. ET to provide a corporate update and review the Company’s results for the quarter ended September 30, 2023.
Individuals may participate in the live call via telephone by dialing (855) 327-6837 (domestic) or (631) 891-4304 (international). The webcast can be accessed live here on the Financials page in the Investors section of the MindMed website, https://mindmed.co/ . The webcast will be archived on the Company’s website for at least 30 days after the conference call.
About MindMed
MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders.
MindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231026654127/en/
For Media & Investor Inquiries, please contact:
Maxim Jacobs, CFA
Vice President, Investor Relations and Corporate Communications
Mind Medicine (MindMed) Inc.
ir@mindmed.co
media@mindmed.co
Source: Mind Medicine (MindMed) Inc.
When is MindMed hosting the conference call?
MindMed is hosting the conference call on Thursday, November 2, 2023.
How can individuals participate in the live call?
Individuals can participate in the live call by dialing (855) 327-6837 (domestic) or (631) 891-4304 (international).
Where can the webcast be accessed?
The webcast can be accessed live on the Financials page in the Investors section of the MindMed website, https://mindmed.co/.
Will the webcast be available after the conference call?
Yes, the webcast will be archived on the Company's website for at least 30 days after the conference call.
MNMD Rankings
#3068 Ranked by Stock Gains
MNMD Stock Data
Industry
Medicinal and Botanical Manufacturing
Sector
Manufacturing
Country
Canada
City
Vancouver
About MNMD
Mind Medicine Inc., also known as MindMed, is a New York-based psychedelic medicine biotech company that develops psychedelic-inspired medicines known as psychoplastogens and therapies to address addiction and mental illness.